Q3ZBK2
Gene name |
PRXL2A (FAM213A, PAMM) |
Protein name |
Peroxiredoxin-like 2A |
Names |
Peroxiredoxin-like 2 activated in M-CSF stimulated monocytes, Protein PAMM, Redox-regulatory protein FAM213A |
Species |
Bos taurus (Bovine) |
KEGG Pathway |
bta:534049 |
EC number |
|
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for Q3ZBK2
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-Q3ZBK2-F1 | Predicted | AlphaFoldDB |
23 variants for Q3ZBK2
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| rs209608567 | 11 | I>V | No | EVA | |
| rs454699827 | 36 | E>G | No | EVA | |
| rs440233884 | 41 | I>T | No | EVA | |
| rs458689835 | 44 | K>T | No | EVA | |
| rs470367159 | 45 | T>I | No | EVA | |
| rs110300397 | 57 | A>V | No | EVA | |
| rs455797103 | 61 | K>R | No | EVA | |
| rs134830652 | 79 | E>G | No | EVA | |
| rs438651588 | 95 | G>S | No | EVA | |
| rs799285801 | 96 | V>A | No | EVA | |
| rs136591424 | 96 | V>I | No | EVA | |
| rs481827374 | 100 | A>S | No | EVA | |
| rs448859182 | 115 | P>L | No | EVA | |
| rs467237162 | 117 | F>L | No | EVA | |
| rs479291938 | 123 | L>V | No | EVA | |
| rs456159870 | 160 | S>C | No | EVA | |
| rs443994566 | 160 | S>T | No | EVA | |
| rs441768647 | 170 | L>R | No | EVA | |
| rs460710365 | 173 | V>A | No | EVA | |
| rs722921155 | 174 | F>L | No | EVA | |
| rs479223729 | 175 | V>M | No | EVA | |
| rs479355427 | 184 | L>R | No | EVA | |
| rs447026167 | 187 | H>D | No | EVA |
No associated diseases with Q3ZBK2
No regional properties for Q3ZBK2
| Type | Name | Position | InterPro Accession |
|---|---|---|---|
| No domain, repeats, and functional sites for Q3ZBK2 | |||
2 GO annotations of cellular component
| Name | Definition |
|---|---|
| cytoplasm | The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
| extracellular region | The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite. |
1 GO annotations of molecular function
| Name | Definition |
|---|---|
| antioxidant activity | Inhibition of the reactions brought about by dioxygen (O2) or peroxides. Usually the antioxidant is effective because it can itself be more easily oxidized than the substance protected. The term is often applied to components that can trap free radicals, thereby breaking the chain reaction that normally leads to extensive biological damage. |
1 GO annotations of biological process
| Name | Definition |
|---|---|
| regulation of osteoclast differentiation | Any process that modulates the frequency, rate or extent of osteoclast differentiation. |
| 10 | 20 | 30 | 40 | 50 | 60 |
| MGMWSIGAGA | IGVAALALLL | ANTDMFLAKP | EKAALEYLED | IDLKTLEKDA | VTFKAKALWE |
| 70 | 80 | 90 | 100 | 110 | 120 |
| KNGAVIMAVR | RPGCFLCREE | ATDLSSLKPK | LDELGVPLYA | VVKEHIKNEV | KDFQPYFKGE |
| 130 | 140 | 150 | 160 | 170 | 180 |
| IFLDENKKFY | GPQRRKMMFM | GFVRLGVWQN | FFRAWNGGFS | GNLDGEGFIL | GGVFVMGPGK |
| 190 | 200 | 210 | |||
| QGILLEHREK | EFGDKVNLTS | VLEAARKIRP | QTSASEKQ |